Immunovant, Inc. Annual Return On Assets in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Immunovant, Inc. quarterly/annual Return On Assets history and growth rate from 2020 to 2023.
  • Immunovant, Inc. Return On Assets for the quarter ending September 30, 2024 was -52 %, a 23.3% increase year-over-year.
  • Immunovant, Inc. annual Return On Assets for 2023 was -59.3 %, a 41.5% decline from 2022.
  • Immunovant, Inc. annual Return On Assets for 2022 was -41.9 %, a 6.26% decline from 2021.
  • Immunovant, Inc. annual Return On Assets for 2021 was -39.4 %, a 56.8% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -59.3 -17.4 -41.5% Apr 1, 2023 Mar 31, 2024
2022 -41.9 -2.47 -6.26% Apr 1, 2022 Mar 31, 2023
2021 -39.4 +51.8 +56.8% Apr 1, 2021 Mar 31, 2022
2020 -91.2 Apr 1, 2020 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.